Skip to main content

Advertisement

Table 2 Detailed location of PET-positive inguinal LN at primary diagnosis of anal cancer

From: Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines

Pat. NoLN NoLN station Cranio-caudal distance in cmVessels radial distance in cm
   LN DiameterSaphenous junction (RTOG)Anal vergeLesser tuberosity (AGITG)Lesser trochanter (BNG)Fem.Saph.Skin
11inferior1.2−1+ 2.1+ 2.4+ 31.20.60.8
 2inferior1.4-1+ 2.1+ 2.4+ 31.40.71.1
23superomedial1.70+ 0.9+ 1.5+ 2.42.10.9
 4superomedial1.6−3−0.50+ 1.02.40.81.2
 5inferior1.5−4−1.5− 0.501.40.91.2
 6inferior1.3−3−0.5+ 0.5+ 1.02.11.00.7
 7inferior1.0−1+ 1.0+ 1.5+4.00.80.91.6
38superomedial1.0−0.33.33.33.91.10.50.9
49inferior1.2−5.5−2.5−2.5−0,51.80.71.6
 10inferior2.6−300+ 22.41.02.1
 11inferior1.0-300+ 21.70.72.5
 12inferior1.0−2.5+ 1.0+ 0.5+ 2.50.80.62.9
 13profound2.60+4+ 3+4.51.71.31.2
 14superolateral2.1+ 1.5+ 5+4+ 62.60.8
 15superolateral0.8+4.5+ 7+ 6.0+ 7.52.80.6
 16inferior1.0−2+ 3+ 1.5+4.00.71.12.9
 17superomedial2.3−1.2+ 3.6+ 4.1+ 5.71.41.31.1
 18profound0.6+ 3.3+ 6.3+ 7.2+ 8.90.43.9
 19profound1.0+4.5+ 7.5+ 7.8+ 9.30.84.5
 20profound0.6+ 1.3+4.3+4.8+ 6.70.42.8
 21profound1.0+ 2.9+ 5.4+ 5.4+ 7.30.63.0
 22profound0.9+ 3.2+ 6.4+ 7.3+ 8.90.72.4
523superomedial0.9−1.4+ 5.5+ 3.4+ 5.40.70.72.7
624superomedial1.1+ 1,4+ 7.5+ 5.1+ 6.60.70.70.9
725superomedial1.4+ 2.5+ 7.4+ 6.3+ 6.42.52.8
826superomedial1.3−1.6+ 3,6+ 3,6+ 3,61.40.62.9
 27profound1.9−1.8+ 3.9+ 3.9+ 3.71.31.01.6
 28profound2.10+4.3+4.5+4.41.11.53.1
 29profound1.20+ 5.2+ 5.2+ 5.31.91.52.4
 30superolateral1.4+ 2.3+ 5.5+ 5.4+ 5.41.72.1
 31profound1.0+ 2.0+ 5.3+ 5.3+ 5.40.65.5
932superomedial1.3+ 2.1+ 5.1+ 5.6+ 7.00.70.7
 33profound1.6+ 1.6+ 5.6+ 5.0+ 6.40.90.9
1034inferior1.4−5.7−2.6−0.7−0.22.80.81.3
 35inferior1.3−5.6−2.6−0.602.30.71.5
 36inferior1.5−2.8−0.7+ 1.33.21.30.81.3
 37inferior1.2−2.8−0.7+ 1.4+ 3.31.40.81.5
 38superomedial0.9−1.9+ 1.3+ 3.4+4.31.70.41.3
 39superolateral1.2− 0.6+ 3.1+ 5.1+ 61.30.7
 40profound1.0+ 1.5+ 3.9+ 5.8+ 6.90.70.8
 41profound1.0+ 2.5+4.9+ 6.8+ 7.90.61.5
 42inferior0.8−1.9+ 1.4+ 3.4+4.30.70.41.0
 43profound1.2−1.6+ 2.1+4.1+ 5.10.81.03.0
 44superomedial1.0+ 1.5+ 3.9+ 5.9+ 7.01.51.4
 45superomedial0.9+ 2.4+4.9+ 6.9+ 7.81.41.1
 46profound0.8+ 2.4+4.9+ 6.9+ 7.91.50.8
 47profound0.7+ 2.3+4.8+ 6.8+ 7.81.30.3
 48superolateral0.7+ 3.4+ 5.3+ 7.3+ 8.30.90.6
 49superolateral0.8+ 3.95.9+ 7.8+ 8.91.10.6
  1. LN = Lymph node, Pat. = Patient, No = number, cm = centimetre, Saph. = great saphenous vein, Fem. = femoral vessels. RTOG = Radiation Oncology Group, AGITG = Australasian Gastrointestinal Trials Group, BNG = British National Guidance. + = cranial distance, − = caudal distance. Red = LN mainly outside elective CTV.